Innate Pharma S.A. (LON:0EVI)
London flag London · Delayed Price · Currency is GBP · Price in EUR
1.419
+0.021 (1.50%)
At close: Feb 12, 2026

Innate Pharma Market Cap

Innate Pharma has a market cap or net worth of 115.42 million as of February 12, 2026. Its market cap has decreased by -15.12% in one year.

Market Cap
115.42M
Enterprise Value
86.67M
Revenue
10.83M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.42

Market Cap Chart

Since November 1, 2006, Innate Pharma's market cap has increased from 530.53K to 115.42M, an increase of 21,655.49%. That is a compound annual growth rate of 32.17%.

History

DateMarket Cap% Change
Feb 12, 2026115.42M-10.41%
Dec 31, 2025128.82M-2.60%
Dec 31, 2024132.26M-27.85%
Dec 29, 2023183.31M-21.67%
Dec 30, 2022234.02M-20.77%
Dec 31, 2021295.36M20.59%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 29, 2017 Pro Pro
Dec 30, 2016 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Dialight123.34M
Evoke122.82M
Rainbow Rare Earths122.41M
Speedy Hire122.10M
Multitude AG119.15M
Tullow Oil118.59M
Macfarlane Group114.45M
Castings P.L.C.113.91M
Market Cap Rankings